- Dúvidas?
- 61 2191-5070
- contato@vbrf.com.br
fludeoxyglucose F18
FDG (Fludeoxyglucose F18) is one of the essential radiopharmaceuticals in modern Nuclear Medicine. Its use is indispensable in PET/CT (Positron Emission Tomography) examinations, enabling detailed metabolic analysis in oncology, neurology, and cardiology. Through this technology, it is possible to obtain accurate diagnoses and monitor treatment effectiveness.
With 17 years of experience, Villas Boas Radiofármacos has established itself as a national reference and one of the pioneers in the production of this radiopharmaceutical in Brazil. Our trajectory is defined by our commitment to innovation and safety. Over more than a decade and a half, we have refined our processes to ensure products that meet the complex demands of Nuclear Medicine services.
Production at our facilities follows international Good Manufacturing Practices (GMP). We operate with state‑of‑the‑art infrastructure, where each batch undergoes strict controls to ensure:
Guaranteeing clear images and reliable results.
Full biological safety for clinical use.
Strict adherence to ANVISA standards and international regulatory bodies.
By choosing Villas Boas, you benefit from the expertise of a leading company recognized for operational consistency and logistical punctuality—critical factors given the short half‑life of this type of radiopharmaceutical.
We continue to advance and invest in cutting‑edge technology to offer the most modern solutions in Nuclear Medicine, actively contributing to diagnostic and nuclear medicine throughout Brazil.
Contact us for inquiries and questions about our products and services.
